Archive · 18 Dec 2025
Global Cancer Treatment Breakthroughs 2025
In 2025, there have been many exciting advancements in cancer treatment.
Doctors have developed new drugs that can target specific types of cancer cells, like those in breast cancer.
They are also using the body's own immune system to fight cancer, which has shown great promise.
In India, scientists have created their own versions of these treatments that are more affordable.
Additionally, computers are being used to help doctors detect cancer earlier and choose the best treatments.
There are also new types of radiation that can target cancer cells more precisely.
The Indian government is working to make these treatments more available to everyone.
These breakthroughs mean that cancer treatment is becoming more effective and personalized, giving patients better chances of recovery.
FDA approved Antibody Drug Conjugates for first-line treatment of advanced HER2-positive breast cancer, showing significant increases in progression-free survival and high tumor response rates.
Checkpoint inhibitors extended to perioperative use in locally advanced head and neck cancers, reflecting robust evidence from pivotal trials.
India has developed indigenous CAR-T products like Qartemi and NexCAR19, delivering world-class outcomes at a fraction of Western prices.
AI-driven algorithms are accelerating early detection, risk stratification, and treatment selection, making personalized oncology more feasible.
Government plans to expand cancer daycare centers, enhance drug availability by reducing duties on life-saving medicines, and integrate oncology care into broader health systems.
- Who
- Oncologists and researchers globally, with a focus on India
- What
- Breakthroughs in cancer treatment including targeted therapies, immunotherapy, cellular therapy, AI, genomics, and radiopharmaceuticals
- When
- Throughout 2025
- Where
- Globally, with specific focus on India
- Why
- To improve survival rates, accessibility, and personalized care for cancer patients
- Targeted Therapies
- FDA approved Antibody Drug Conjugates for HER2-positive breast cancer
- Immunotherapy
- Checkpoint inhibitors extended to head and neck cancers
- Cellular Therapy
- Indigenous CAR-T products like Qartemi and NexCAR19
- AI and Genomics
- AI-driven algorithms for early detection and treatment selection
- Radiopharmaceuticals
- Alpha-emitter based theranostics for PSMA and neuroendocrine tumors
- India's Initiatives
- Government plans to expand cancer daycare centers and reduce drug duties